Health Inequities in Persons with Obesity & Type 2 Diabetes Exacerbated During COVID-19 Pandemic
Any viral infection can be a stressor for patients with obesity and type 2 diabetes (T2D), a population at risk for reduced immunity, however, “COVID-19 was huge,” said Shagun Bindlish, MD, medical director of One Medical in Dublin, California, in a recent interview with Patient Care Online. Dr Bindlish, joined by Dr Peminda K. Cabandugama, director of Digital Obesity at the Cleveland Clinic, sat down with Patient Care® to discuss the impact of the COVID-19 pandemic on obesity-related T2D, including the effect of quarantine and social distancing measures on overall health and how inequities were exacerbated in certain patient populations. More of their conversation follows.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
